🇺🇸
United States · US · US:0480-9742_356f2fbd-1b94-4809-8b46-bc314bc2ae18
lisdexamfetamine dimesylate
In shortageOrange BookUNIISPLATC N06BA
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerTeva Pharmaceuticals, Inc.
CountryUS (United States)
ATC codeN06BA
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc110480974201100 TABLET, CHEWABLE in 1 BOTTLE (0480-9742-01)
Annotations
UNII (FDA Substance ID)
SJT761GEGS
LISDEXAMFETAMINE DIMESYLATE
RxCUI 673579
Orange Book
A215415
ABABABABABAB
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Lisdexamfetamine Dimesylate Capsule
Raw payload (JSON)
{
"unii": {
"unii": "SJT761GEGS",
"rxcui": "673579",
"inchikey": "CETWSOHVEGTIBR-FORAGAHYSA-N",
"display_name": "LISDEXAMFETAMINE DIMESYLATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"6740a621-9bec-4178-a4fc-a3fc89f34e0a": {
"match": "brand_token",
"title": "LISDEXAMFETAMINE DIMESYLATE CAPSULE [HIKMA PHARMACEUTICALS USA INC.]",
"spl_version": "7",
"published_date": "2026-05-28"
}
},
"productid": "0480-9742_356f2fbd-1b94-4809-8b46-bc314bc2ae18",
"productndc": "0480-9742",
"dosage_form": "TABLET, CHEWABLE",
"orange_book": {
"appl_no": "215415",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "10MG",
"product_no": "001",
"approval_date": "Aug 25, 2023"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "20MG",
"product_no": "002",
"approval_date": "Aug 25, 2023"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "30MG",
"product_no": "003",
"approval_date": "Aug 25, 2023"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "40MG",
"product_no": "004",
"approval_date": "Aug 25, 2023"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "50MG",
"product_no": "005",
"approval_date": "Aug 25, 2023"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "60MG",
"product_no": "006",
"approval_date": "Aug 25, 2023"
}
],
"appl_type": "A"
},
"dea_schedule": "CII",
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "LISDEXAMFETAMINE DIMESYLATE",
"shortage_reason": "Lisdexamfetamine Dimesylate Capsule",
"shortage_status": "current",
"proprietary_name": "lisdexamfetamine dimesylate",
"active_ingred_unit": "mg/1",
"application_number": "ANDA215415",
"marketing_category": "ANDA",
"nonproprietary_name": "lisdexamfetamine dimesylate",
"start_marketing_date": "20240916",
"active_numerator_strength": "50"
}Related drugs
Other records sharing ATC code N06BA.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTakeda Pharmaceuticals America, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
Access this data programmatically
Query lisdexamfetamine dimesylate and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.